Big Pharma Is in a Frenzy to Bring Cannabis-Based Medicines to Market
Share and save this post:
AlterNet Social Networks:
Also in DrugReporter
When It’s Crunch Time at College, Students Turn to Adderall
Erik Hayden
In Historic Shift, the American Medical Association Sees Value in Marijuana
Phillip S. Smith
The Relentless War on Drug Users Is Escalating Violence in the US: It's Time for Harm Reduction
Don Hazen
Drug Policy Alliance Conference Comes at a Crucial Moment for Drug Reform
Anthony Papa
Why Are We Locking Up Traumatized Veterans for Their Addictions Instead of Offering Them Treatment?
Penny Coleman
Lies About Marijuana Drive People to a Much More Harmful Drug -- Booze
Steve Fox
See more stories tagged with: big pharma, medical marijuana, theory
Paul Armentano is the senior policy analyst for the NORML Foundation in Washington, DC.
Liked this story? Get top stories in your inbox each week from DrugReporter! Sign up now »
You've chosen to turn comments off for the entire site. Would you like to turn them back on?
Support AlterNet
Do you value the information you're getting from AlterNet? Please show your support with a tax-deductible donation.
Feedback
Tell us how we're doing.
EMAIL
PRINT
75 COMMENTS
